Home/Filings/4/0001225208-12-004838
4//SEC Filing

Edwards Lifesciences Corp 4

Accession 0001225208-12-004838

$EWCIK 0001099800operating

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:37 PM ET

Size

8.7 KB

Accession

0001225208-12-004838

Insider Transaction Report

Form 4
Period: 2012-02-17
REINDL ROBERT C
CVP, H.R. and Communications
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2012-02-1724,50024,500 total
    Exercise: $22.95From: 2006-05-12Exp: 2012-05-11Common Stock (24,500 underlying)
  • Exercise/Conversion

    Common Stock

    2012-02-17$22.95/sh+24,500$562,27530,276 total
  • Sale

    Common Stock

    2012-02-17$75.96/sh24,500$1,861,0205,776 total
Footnotes (2)
  • [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $75.68 to $76.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001099800

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:37 PM ET
Size
8.7 KB